Dopaminergic agonists for hepatic encephalopathy

B Als-Nielsen; L L Gluud; C Gluud

doi:10.1002/14651858.CD003047.pub2

Dopaminergic agonists for hepatic encephalopathy

B Als-Nielsen, L L Gluud, C Gluud

Copenhagen Trial Unit

24 Citations (Scopus)

Abstract

Hepatic encephalopathy may be associated with an impairment of the dopaminergic neurotransmission. Dopaminergic agonists may therefore have a beneficial effect on patients with hepatic encephalopathy.

Original language	English
Journal	Cochrane Database of Systematic Reviews
Issue number	4
Pages (from-to)	CD003047
ISSN	1469-493X
DOIs	https://doi.org/10.1002/14651858.CD003047.pub2
Publication status	Published - 2004

Keywords

Dopamine Agonists
Hepatic Encephalopathy
Humans
Randomized Controlled Trials as Topic

Access to Document

10.1002/14651858.CD003047.pub2

Cite this

@article{70a2ea07bfb74662b7369cb2c17c4228,

title = "Dopaminergic agonists for hepatic encephalopathy",

abstract = "Hepatic encephalopathy may be associated with an impairment of the dopaminergic neurotransmission. Dopaminergic agonists may therefore have a beneficial effect on patients with hepatic encephalopathy.",

keywords = "Dopamine Agonists, Hepatic Encephalopathy, Humans, Randomized Controlled Trials as Topic",

author = "B Als-Nielsen and Gluud, \{L L\} and C Gluud",

year = "2004",

doi = "10.1002/14651858.CD003047.pub2",

language = "English",

pages = "CD003047",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley and Sons Ltd",

number = "4",

}

TY - JOUR

T1 - Dopaminergic agonists for hepatic encephalopathy

AU - Als-Nielsen, B

AU - Gluud, L L

AU - Gluud, C

PY - 2004

Y1 - 2004

N2 - Hepatic encephalopathy may be associated with an impairment of the dopaminergic neurotransmission. Dopaminergic agonists may therefore have a beneficial effect on patients with hepatic encephalopathy.

AB - Hepatic encephalopathy may be associated with an impairment of the dopaminergic neurotransmission. Dopaminergic agonists may therefore have a beneficial effect on patients with hepatic encephalopathy.

KW - Dopamine Agonists

KW - Hepatic Encephalopathy

KW - Humans

KW - Randomized Controlled Trials as Topic

UR - https://www.scopus.com/pages/publications/16644364818

U2 - 10.1002/14651858.CD003047.pub2

DO - 10.1002/14651858.CD003047.pub2

M3 - Journal article

C2 - 15495041

SN - 1469-493X

SP - CD003047

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 4

ER -

Dopaminergic agonists for hepatic encephalopathy

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this